Aclarion, Inc., (ACON): Price and Financial Metrics


Aclarion, Inc., (ACON): $0.70

-0.03 (-4.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ACON Stock Price Chart Interactive Chart >

Price chart for ACON

ACON Price/Volume Stats

Current price $0.70 52-week high $4.05
Prev. close $0.73 52-week low $0.38
Day low $0.70 Volume 3,608
Day high $0.77 Avg. volume 35,487
50-day MA $0.73 Dividend yield N/A
200-day MA $0.84 Market Cap 5.50M

Aclarion, Inc., (ACON) Company Bio


Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.


ACON Latest News Stream


Event/Time News Detail
Loading, please wait...

ACON Latest Social Stream


Loading social stream, please wait...

View Full ACON Social Stream

Latest ACON News From Around the Web

Below are the latest news stories about ACLARION INC that investors may wish to consider to help them evaluate ACON as an investment opportunity.

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion to participate in upcoming SPINEWEEK 2023 Broomfield, CO, March 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announce

Yahoo | March 7, 2023

Aclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON)(NASDAQ:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain (CLBP), has been invited to present at the Third Annual Winter Wonderland - Best Ideas Virtual Investor conference, which is being held virtually on February 21st - 24th, 2023.

Yahoo | February 16, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for trader need to kno about Wednesday!

William White on InvestorPlace | February 15, 2023

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

NociscanTM is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological pain. Nociscan provides decision support to help bridge a major diagnostic void. Robert Eastlack, MD will speak to his real-world experience using Nociscan to effectively evaluate CLBP. BROOMFIELD, CO , Feb. 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is lev

Yahoo | February 15, 2023

Insiders who bought stock earlier this year lose -US$213k as Aclarion, Inc. (NASDAQ:ACON) drops to US$4.7m

Insiders who acquired US$278k worth of Aclarion, Inc.'s ( NASDAQ:ACON ) stock at an average price of US$2.59 in the...

Yahoo | February 5, 2023

Read More 'ACON' Stories Here

ACON Price Returns

1-mo -3.99%
3-mo 20.69%
6-mo -10.03%
1-year N/A
3-year N/A
5-year N/A
YTD 20.69%
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7747 seconds.